MR Imaging Characteristics of Solitary Fibrous Tumors of the Orbit : Case Series of 18 Patients.

MR imaging MR orbit Orbital tumor SFT Solitary fibrous tumor

Journal

Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693

Informations de publication

Date de publication:
08 Mar 2024
Historique:
received: 16 01 2024
accepted: 14 02 2024
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: aheadofprint

Résumé

Solitary fibrous tumor (SFT) of the orbit is a rare tumor that was first described in 1994. We aimed to investigate its imaging characteristics that may facilitate the differential diagnosis between SFT and other types of orbital tumors. Magnetic resonance imaging (MRI) data of patients with immunohistochemically confirmed orbital SFT from 2002 to 2022 at a tertiary care center were retrospectively analyzed. Tumor location, size, morphological characteristics, and contrast enhancement features were evaluated. Of the 18 eligible patients 10 were female (56%) with a mean age of 52 years. Most of the SFTs were oval-shaped (67%) with a sharp margin (83%). The most frequent locations were the laterocranial quadrant (44%), the extraconal space (67%) and the dorsal half of the orbit (67%). A flow void phenomenon was observed in nearly all cases (94%). On the T1-weighted imaging, tumor signal intensity (SI) was significantly lower than that of the retrobulbar fat and appeared predominantly equivalent (82%) to the temporomesial brain cortex, while on T2-weighted imaging its SI remained equivalent (50%) or slightly hyperintense to that of brain cortex. More than half of the lesions showed a homogeneous contrast enhancement pattern with a median SI increase of 2.2-fold compared to baseline precontrast imaging. The SFT represents a rare orbital tumor with several characteristic imaging features. It was mostly oval-shaped with a sharp margin and frequently localized in the extraconal space and dorsal half of the orbit. Flow voids indicating hypervascularization were the most common findings.

Identifiants

pubmed: 38456912
doi: 10.1007/s00062-024-01400-8
pii: 10.1007/s00062-024-01400-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Klemperer P and Rabin CB. Primary Neoplasms of the Pleura. A Report of Five Cases. Archives of Pathology. 1931;11:385–412.
Westra WH, Gerald WL, Rosai J. Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Surg Pathol. 1994;18(10):992–8.
doi: 10.1097/00000478-199410000-00003 pubmed: 7522416
Geramizadeh B, Marzban M, Churg A. Role of Immunohistochemistry in the Diagnosis of Solitary Fibrous Tumor, a Review. Iran J Pathol. 2016;11(3):195–203.
pubmed: 27799967 pmcid: 5079451
Blessing NW, et al. Solitary Fibrous Tumor of the Orbit: A Case Series With Clinicopathologic Correlation and Evaluation of STAT6 as a Diagnostic Marker. Ophthalmic Plast Reconstr Surg. 2020;36(2):164–71.
doi: 10.1097/IOP.0000000000001504 pubmed: 31876648 pmcid: 7060103
Bernardini, F.P., et al., Solitary fibrous tumor of the orbit: is it rare? Report of a case series and review of the literature. Ophthalmology, 2003. 110(7): p. 1442–8.
Bonavolontà G, et al. An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011. Ophthalmic Plast Reconstr Surg. 2013;29(2):79–86.
doi: 10.1097/IOP.0b013e31827a7622 pubmed: 23470516
Huang A, et al. Orbital primary solitary fibrous tumor: a proposed recurrence risk prediction model based on 92 cases. Hum Pathol. 2023;137:85–93.
doi: 10.1016/j.humpath.2023.04.018 pubmed: 37127080
Zhang Z, et al. Value of MR imaging in differentiation between solitary fibrous tumor and schwannoma in the orbit. AJNR Am J Neuroradiol. 2013;34(5):1067–71.
doi: 10.3174/ajnr.A3340 pubmed: 23306015 pmcid: 7964636
Kim HJ, et al. Solitary fibrous tumor of the orbit: CT and MR imaging findings. AJNR Am J Neuroradiol. 2008;29(5):857–62.
doi: 10.3174/ajnr.A0961 pubmed: 18272558 pmcid: 8128581
Masuno R, et al. Magnetic Resonance Imaging of Orbital Solitary Fibrous Tumors: Radiological-Pathological Correlation Analysis. J Belg Soc Radiol. 2021;105(1):14.
doi: 10.5334/jbsr.2097 pubmed: 33778369 pmcid: 7977021
Ren J, et al. MRI-based radiomics nomogram for distinguishing solitary fibrous tumor from schwannoma in the orbit: a two-center study. Eur Radiol. 2023;.
Yang BT, et al. MRI study of solitary fibrous tumor in the orbit. AJR Am J Roentgenol. 2012;199(4):W506–11.
doi: 10.2214/AJR.11.8477 pubmed: 22997401
Thompson LD, Liou SS, Feldman KA. Orbit solitary fibrous tumor: a proposed risk prediction model based on a case series and comprehensive literature review. Head and Neck Pathol. 2021;15:138–52.
doi: 10.1007/s12105-020-01184-6
Jackson CH, Hunt BC, Harris GJ. Fate and Management of Incompletely Excised Solitary Fibrous Tumor of the Orbit: A Case Series and Literature Review. Ophthalmic Plast Reconstr Surg. 2021;37(2):108–17.
doi: 10.1097/IOP.0000000000001691 pubmed: 32496393
Yazıcı B, et al. Preoperative Endovascular Embolization of Orbital Solitary Fibrous Tumor With 500–700 Micron Tris-Acryl Gelatin Microspheres. Turk J Ophthalmol. 2022;52(5):356–9.
doi: 10.4274/tjo.galenos.2022.79438 pubmed: 36317827 pmcid: 9631504
Vijitha VS, et al. Preoperative embolisation of orbital solitary fibrous tumour. BMJ Case Rep. 2020;13(12).
Demura M, et al. Intraorbital Solitary Fibrous Tumor Requiring Preoperative Embolization of Feeding Artery. Asian J Neurosurg. 2019;14(2):593–7.
doi: 10.4103/ajns.AJNS_30_19 pubmed: 31143292 pmcid: 6516021
Zhang L, et al. Diagnostic Imaging Methods and Comparative Analysis of Orbital Cavernous Hemangioma. Front Oncol. 2020;10:577452.
doi: 10.3389/fonc.2020.577452 pubmed: 33072609 pmcid: 7539693
Goldstein HE, Solomon RA. Epidemiology of cavernous malformations. Handb Clin Neurol. 2017;143:241–7.
doi: 10.1016/B978-0-444-63640-9.00023-0 pubmed: 28552146
Xian J, et al. Evaluation of MR imaging findings differentiating cavernous haemangiomas from schwannomas in the orbit. Eur Radiol. 2010;20(9):2221–8.
doi: 10.1007/s00330-010-1774-y pubmed: 20393718 pmcid: 2914262
Kalicińska E, et al. A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG). Cancer Med. 2023;12(3):3036–45.
doi: 10.1002/cam4.5223 pubmed: 36161781
Ren J, et al. Differentiation of orbital lymphoma and idiopathic orbital inflammatory pseudotumor: combined diagnostic value of conventional MRI and histogram analysis of ADC maps. BMC Med Imaging. 2018;18(1):6.
doi: 10.1186/s12880-018-0246-8 pubmed: 29716527 pmcid: 5930683
Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol. 2019;64(1):45–66.
doi: 10.1016/j.survophthal.2018.08.002 pubmed: 30144455
Priego G, et al. Orbital lymphoma: imaging features and differential diagnosis. Insights Imaging. 2012;3(4):337–44.
doi: 10.1007/s13244-012-0156-1 pubmed: 22695946 pmcid: 3481074
Yuen SJ, Rubin PA. Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin North Am. 2002;15(1):121–6.
doi: 10.1016/S0896-1549(01)00003-7 pubmed: 12064075
Yeşiltaş YS, Idiopathic Orbital Inflammation AKG. Review of Literature and New Advances. Middle East Afr J Ophthalmol. 2018;25(2):71–80.
doi: 10.4103/meajo.MEAJO_44_18 pubmed: 30122852 pmcid: 6071347
Sweeney AR, et al. Orbital peripheral nerve sheath tumors. Surv Ophthalmol. 2017;62(1):43–57.
doi: 10.1016/j.survophthal.2016.08.002 pubmed: 27570221
Wang Y, Xiao LH. Orbital schwannomas: findings from magnetic resonance imaging in 62 cases. Eye (Lond). 2008;22(8):1034–9.
doi: 10.1038/sj.eye.6702832 pubmed: 17464300
Cuenod C, Balvay D. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI. Diagn Interv Imaging. 2013;94(12):1187–204.
doi: 10.1016/j.diii.2013.10.010 pubmed: 24211260
Le Y, et al. Development and evaluation of TWIST Dixon for dynamic contrast-enhanced (DCE) MRI with improved acquisition efficiency and fat suppression. J Magn Reson Imaging. 2012;36(2):483–91.
doi: 10.1002/jmri.23663 pubmed: 22544731
Xu X‑Q, et al. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging. Medicine. 2019;98:12.

Auteurs

Christoph Ziegenfuß (C)

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany. ChristophDavid.Ziegenfuss@uk-essen.de.

Natalie van Landeghem (N)

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.

Chiara Meier (C)

Department of Oral and Maxillofacial Surgery, University Hospital Essen, Kliniken-Essen-Mitte, Henricistraße 92, 45136, Essen, Germany.

Roman Pförtner (R)

Department of Oral and Maxillofacial Surgery, University Hospital Essen, Kliniken-Essen-Mitte, Henricistraße 92, 45136, Essen, Germany.

Anja Eckstein (A)

Department of Ophthalmology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.

Philipp Dammann (P)

Department of Neurosurgery and Spine Surgery, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.

Patrizia Haubold (P)

Department of Diagnostic and Interventional Radiology, Kliniken Essen-Mitte, Henricistraße 92, 45136, Essen, Germany.

Johannes Haubold (J)

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.

Michael Forsting (M)

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.

Cornelius Deuschl (C)

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.

Isabel Wanke (I)

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.
Swiss Neuroradiology Institute, Bürglistraße 29, 8002, Zürich, Switzerland.

Yan Li (Y)

Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstraße 55, 45147, Essen, Germany.

Classifications MeSH